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Abstract
Background Electrolyte values are measured both by
arterial blood gas (ABG) analyzers and central laboratory
auto-analyzers (AA), but a significant time gap exists
between the availability of both these results, with the
ABG giving faster results than the AA. The authors
hypothesized that there is no difference between the results
obtained after measurement of electrolytes by the blood gas
and auto-analyzers.
Methods After approval by the ethics committee, an
observational cohort study was conducted in which 200
paired venous and arterial samples from patients admitted
to the Medical Intensive Care Unit (ICU) of Apollo
Hospital, Hyderabad, India, were analyzed for electrolytes
on the ABG machine and the AA. Analyses were done on
the ABL555 blood gas analyzer and the Dade Dimension
RxL Max, both located in the central laboratory. Statistical
analyses were performed using paired Student’s t test.
Results A total of 200 paired samples were analyzed. The
mean ABG sodium value was 131.28 (SD 7.33), and the
mean AA sodium value was 136.45 (SD 6.50) (p<0.001).
The mean ABG potassium value was 3.74 (SD 1.92),
and the mean AA potassium value was 3.896 (SD 1.848)
(p=0.2679).
Conclusion Based on the above analysis, the authors found
no significant difference between the potassium values
measured by the blood gas machine and the auto-analyzer.
However, the difference between the measured sodium was
found to be significant. We therefore conclude that critical
decisions can be made by trusting the potassium values
obtained from the arterial blood gas analysis.
Introduction
Point-of-care testing enables clinicians to initiate appropri-
ate treatment for emergent conditions, thereby benefitting
the patient both clinically and economically [1].
Electrolyte values are conventionally measured for all
critical patients who present to the emergency department,
for patients receiving fluid therapy, and for patients
admitted to intensive care units (ICU).
Routinely, all electrolytes are measured from serum by
the auto-analyzers (AA) available in central laboratories of
hospitals; however, this is time-consuming. Typically, a
turnaround time of about 15 min is noted on average in
acute care laboratories of most tertiary care hospitals for the
above [2]. Quick decisions that need to be made depending
on electrolyte values hence are often made either blindly or
are delayed. Point-of-care testing for electrolytes is avail-
able from specialized equipment such as the iSTAT or Stat
Profile Critical Care Xpress analyzers [3]. The operational
cost of iSTAT and other similar equipment is a major
deterrent to their utilization in developing systems of health
care. Electrolytes are also measured during arterial blood
gas analysis, but are traditionally rarely trusted for clinical
decision-making because of the dearth of published
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machines and AA differ in several aspects as listed in
Table 1 [4].
The United States Clinical Laboratory Improvement
Amendment (US CLIA) 2006 [5] accepts a difference of
0.5 mmol/l in measured potassium, and 4 mmol/l in
measured sodium, from the gold standard measure of
standard calibration solutions.
Previous studies [6] that measured the accuracy of
electrolyte values obtained by ABG machines concluded
that the results from two different measurement technolo-
gies differed significantly for plasma sodium and chloride
concentrations. These differences significantly affected the
calculated anion gap and strong ion difference values.
Others have also found statistically significant differ-
ences in measures of pH, potassium, and hematocrit
between ABG machines and leading bench-top analyzers
[6, 7].
Experts have cited theoretical reasons for these differ-
ences based on the chemical reactions employed in the AA
and the auto-analyzers [8].
1. Dilution with heparin raises the volume of the sample,
thereby lowering the value of the measured electrolytes
on the ABG.
2. High volume of heparin itself binds the electrolytes,
thereby lowering the value of measured electrolytes on
the ABG.
Our study had a null hypothesis that there is no
difference between the electrolyte measurements by the
AA and ABG machines.
Materials and methods
The study was approved by the ethics committee of Apollo
Hospitals, Hyderabad, India. The study was designed to be
an observational study of a consecutive cohort of patients
admitted to the ICU.
Paired blood samples from 200 consecutive adult
patients admitted to the Medical ICU of Apollo Hospitals
were included in the study. The study period started in
August 2005 and ended in May 2006. Blood samples were
collected simultaneously for ABG and AA for electrolyte
analysis. All samples were analyzed on the ABL555 blood
gas analyzer and the Dade Dimension RxL Max, both
located in the central laboratory. Both of these are
considered as benchmark top models in their respective
technologies.
Quality control was ensured by having the blood
samples collected by trained staff of a single ICU unit in
the hospital and analyzed in the two analyzers located in the
central laboratory under similar environmental conditions,
unlike in the previous studies where the analyzers were in
different environments [7]. Both analyzers were calibrated
[10] according to the Joint Commission on Accreditation of
Hospitals (JCAHO) requirements for hospital certification
prior to each measurement cycle. Time of collection of
samples was documented on both sample groups for
reference. Operators drawing and handling blood samples
did so with only latex gloves without using any hand
disinfectants just prior to handling blood [11].
The 200 paired samples included a venous blood sample
for auto-analyzer electrolyte measurement and an arterial
blood sample for blood gas analysis.
Data were collected, and the values of sodium (Na+) and
potassium (K+) from these measurements were compared
using the paired t-test.
Results
The analysis of sodium values (Table 2) showed that the
mean sodium measured on the ABG was 131.28 mmol/L
(SD 7.33), and the mean sodium measured by the AA was
136.45 mmol/L (SD 6.50). The maximum difference in
sodium value was 30 mmol/l, and the minimum difference
was 0mmol/l. The mean difference was 5.96 mmol/l with SD
5.09 (p<0.001, significant difference detected, hence null
hypothesis rejected). The correlation coefficient (r) was 0.68.
The adjusted r
2 was within a 95% confidence interval from
Table 2 Statistical analysis of sodium samples
Sample Mean mmol/l SD
Blood gas analyzer 131.2 7.3
Auto-analyzer 136.4 6.5
Table 1 Differences between the blood gas analyzer and auto-analyzer
Blood gas analyzer Auto-analyzer
Analyzes whole blood Analyzes serum
Arterial sample used
conventionally
Venous sample used conventionally
Uses direct ion selective
electrode
Uses indirect ion-selective electrode
technology
Uses heparin-diluted sample Serum sample diluted with fixed
volume diluent
Processing time is short Processing time is long
No effect of protein levels
in blood
Affected by protein levels in blood
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on the ABG machine were lower than those on the AA.
Sodium analysis was stratified based upon the standard
laboratory values, and 135–145 mmol/l was considered as
normal serum sodium. Anything above was considered
hypernatremia. Patients with serum sodium 120–135 mmol/l
were considered as borderline hyponatremic, and patients
with serum sodium less than 120 mmol/l were diagnosed as
hyponatremic (Table 3). Clinically this was a more signifi-
cant group because only at Na<120 did the clinicians feel it
important to correct sodium emergently.
Analysis of the sodium measurements in the group of
patients with normal sodium revealed a significant differ-
ence between the two measures (p=0.005; null hypothesis
rejected). However, the mean difference between the two
measuring methods was 3.4 mmol/l, which was within the
acceptable limit defined in the US CLIA 2006.
There was no significant difference in sodium measure-
ments by AA and ABG for patients with hypernatremia
(mean difference 3.8 mmol/l; p=0.3847, null hypothesis
accepted). However, because of the small sample size (n=
5) in this subgroup, we were underpowered to detect a
difference.
In the group of patients with borderline hyponatremia
(serum sodium 120–135 mmol/l) and hyponatremia (serum
sodium <120 mmol/l), the mean difference between the two
measurements was 7.4 mmol/l and 12.8 mmol/l (p<0.0001
for both subgroups), effectively making the ABG measure-
ments unreliable.
Analysis of the potassium values (Table 4) obtained from
the AA and the ABG gave a mean difference of 0.46 mmol/l
with a standarderror of 0.03 mmol/l. There was no significant
difference (p=0.2679, null hypothesis accepted) between K+
measured by the ABG (3.7 mmol/l, SD 1.9) and AA (mean
3.9 mmol/l, SD 1.8). The maximum difference in measured
potassium value was 2.4 mmol/l, and the minimum difference
was 0 mmol/l. The correlation coefficient (r) was 0.72. The
adjusted r
2 was within a 95% confidence interval of 0.42 to
0.62. A total of 71.5% of the K+ values obtained on the
ABG was lower than the AA.
Potassium values were stratified (Table 5) based upon
the standard laboratory values. Patients with K+ 3.5–
5.0 mmol/l were normo-kalemic, values above 5.0 mmol/l
were considered as hyperkalemia, and those below
3.5 mmol/l were considered as hypokalemia.
The mean differences in patients with hyperkalemia,
normokalemia, and hypokalemia were 0.44 mmol/l (SD
0.05), 0.46 mmol/l (SD 0.03), and 0.42 mmol/l (SD 0.02),
respectively, all of which are less than the US CLIA 2006
guideline of 0.5 mmol/l.
Discussion
Point-of-care analyzers are force multipliers for clinicians
working in the areas of critical care and emergency
medicine. They have been proven to benefit clinical
decision-making by reducing the turnaround time for
routine biochemical investigations. Time critical decisions
are enabled by point-of-care analyzers when biochemical
parameters are beyond their normal limits. Several kinds of
point-of-care testing equipment are in vogue in clinical
practice today, and they have been widely evaluated in
varied environments.
Point-of-care testing has gained special favor in emer-
gency transport systems, critical care departments, and
cardiothoracic surgical departments, as is shown by the
large volume of systems developed for all of these areas
[12–14].
However, high operational costs are a deterrent to the
application of specialized point-of-care equipment in
developing countries [15]. Direct costs have been decreasing
Table 3 Stratified analysis of difference between Na+ measured by
AA and ABG
Group
mmol/l
Mean
difference
mmol/l
SD
difference
mmol/l
Max.
difference
mmo/l
Min.
difference
mmol/l
P value
>145 3.8 2.77 8.0 1.0 0.3847
135–145 3.4 2.35 12.0 0.0 0.0051
120–135 7.4 4.26 22.0 0.0 <0.0001
<120 12.8 7.19 30.0 6.0 <0.0001
Table 4 Statistical analysis of potassium
Sample Mean mmol/l SD mmol/l
Blood gas analyzer 3.7 1.9
Auto-analyzer 3.9 1.8
Table 5 Stratified analysis of the difference between K+ measured by
AA and ABG
Group
mmol/l
No. of
values
Mean
difference
mmol/l
SD
difference
mmol/l
Max.
difference
mmo/l
Min.
difference
mmol/l
>5.0 58 0.44 0.05 1.8 0.0
3.5–5.0 106 0.46 0.03 1.6 0.0
<3.5 36 0.42 0.02 2.4 0.0
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study was to evaluate existing point-of-care arterial blood
gas analyzers for electrolyte measures. The instrumental
difference between the AA and the ABG analyzers is the
turnaround time to get the results. Also the fact that blood
gas analyzers are unaffected by serum protein levels in their
electrolyte measures is an added advantage to using them as
a point-of-care electrolyte measure in critically ill patients
[16, 17].
Despite the differences that have been cited in the
working of the ABG machine and the AA, this study shows
that there are no significant differences between the K+
measured by the AA and the ABG machines. The authors
therefore suggest that decisions based on serum K+ can be
made by trusting the value obtained on the ABG machine.
The study agrees with previous studies [6] that Na+
values obtained on the ABG machine are not completely
reliable when making clinical decisions. Though statistical-
ly significant, the difference in the measured Na+ values in
hypernatremic and normo-natremic patients was within the
recommended US CLIA guidelines. Whether statistical
difference also translates to clinical difference remains to
be seen.
Some of the limitations of our study are that the results are
limited to the use of one AA and one ABG machine.
However, previous studies comparing blood gas analyzers of
different brands have shown that the measures obtained from
ABG machines are highly statistically concordant [18].
Another limitation was that the ABG samples were
collected using conventional syringes containing liquid
heparin. The use of dried heparin syringes [9] could
improve the accuracy of the results by decreasing the
dilution of the sample.
Previous studies referenced earlier have shown that ABG
machines do not measure electrolytes accurately, but since all
these studies compared results between AA and ABG
analyzers in different environments, we created another
limitation for ourselves by locating the ABG analyzer in the
central laboratory in an environment similar to the AA, and in
doing so we did undermine the true meaning of point-of-care
testing, which is often equated to bed-side testing. However,
the time gain was significant even by following the above
practice since the time for analysis itself was minimized.
In conclusion, we advocate the use of ABG machines for
adjudging serum potassium values accurately, in the
absence of other specialized point-of-care analyzers. Fur-
ther research is needed to establish their accuracy for
sodium values.
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